A systematic review and meta-analysis of clinical trials of antibiotic treatment for children with community-acquired pneumonia provides further support for shorter treatment duration, Finnish researchers reported yesterday in Clinical Infectious Diseases.
A related study shows how responding quickly to food illness outbreaks saves lives and significant money.
An increase in resistance to ciprofloxacin among poultry isolates was primarily due to Salmonella Infantis.
Venatorx Pharmaceuticals of Malvern, Pennsylvania, yesterday released promising data from a phase 3 trial of its investigational new drug for patients with complicated urinary tract infections (cUTIs).
Fewer than half of US states requiring COVID-19 vaccination or routine testing of schoolteachers included childcare professionals in their mandates, leaving some young children vulnerable to infection by unvaccinated caregivers, according to a study yesterday in JAMA Pediatrics.
The risk of hospitalization, intensive care unit (ICU) admission, and death was much lower among more than 9,000 Canadian COVID-19 patients infected with the Omicron variant than among matched Delta patients, according to a study published yesterday in JAMA.
The risk of hospitalization or death with Omicron was 41% of—and the risk of death was one-tenth of—that of Delta.
The severity of COVID-19 does not change based on pregnancy trimester, finds research presented today at the Society for Maternal-Fetal Medicine's (SMFM's) virtual annual meeting.
The US Department of Agriculture (USDA) on Jan 14 announced that highly pathogenic H5N1 avian influenza was detected in a wild wigeon in South Carolina, marking the first time the Eurasian strain of the virus has been detected in the United States since 2016.
The finding follows the recent detection of high-path H5N1 in wild birds and poultry in Canada's Newfoundland and Labrador region.
The US COVID-19 vaccination program may have averted 14 million infections, saved more than 240,000 lives, and prevented upwards of 1.1 million hospitalizations in the first half of 2021, according to estimates from a modeling study yesterday in JAMA Network Open.
A study conducted at a large teaching hospital in Tokyo found that most tests used to diagnose invasive fungal disease were inappropriate, Japanese researchers reported yesterday in Open Forum Infectious Diseases.